Tag: #Global Trends

Chinese market regulators have recently ordered all infant formula producers to conduct mandatory testing for cereulide toxins. This directive follows... Read more

The U.S. Food and Drug Administration (FDA) has issued a refusal-to-file (RTF) letter regarding Moderna’s next-generation mRNA flu vaccine (mRNA-1010),... Read more

AbbVie has struck a pivotal agreement with the U.S. administration, signaling a major evolution in healthcare policy where domestic production... Read more

Takeda has entered into a multi-year strategic partnership with Iambic to utilize artificial intelligence in advancing small molecule drug programs.... Read more

AstraZeneca concluded fiscal year 2025 with total revenue reaching $58.7 billion, an 8% increase compared to the previous year. The... Read more

Despite reporting fourth-quarter 2025 earnings that surpassed Wall Street forecasts, Gilead Sciences saw its stock drop by as much as... Read more

Roche has unveiled compelling Phase 3 data from the FENtrepid trial for fenebrutinib, an oral BTK inhibitor. The brain-penetrating medication... Read more

Eli Lilly (USA) and Innovent Biologics (China) have officially entered their seventh strategic collaboration agreement. This partnership is designed to... Read more

On February 5, 2026, the U.S. government officially unveiled TrumpRx.gov, a direct-to-consumer (DTC) web portal offering significant discounts on over... Read more